Product NDC: | 10019-291 |
Proprietary Name: | Oxytocin |
Non Proprietary Name: | Oxytocin |
Active Ingredient(s): | 10 [USP'U]/mL & nbsp; Oxytocin |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10019-291 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018243 |
Marketing Category: | NDA |
Start Marketing Date: | 20090626 |
Package NDC: | 10019-291-02 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 CARTON (10019-291-02) > 1 mL in 1 VIAL, SINGLE-DOSE (10019-291-12) |
NDC Code | 10019-291-02 |
Proprietary Name | Oxytocin |
Package Description | 25 VIAL, SINGLE-DOSE in 1 CARTON (10019-291-02) > 1 mL in 1 VIAL, SINGLE-DOSE (10019-291-12) |
Product NDC | 10019-291 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Oxytocin |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20090626 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | OXYTOCIN |
Strength Number | 10 |
Strength Unit | [USP'U]/mL |
Pharmaceutical Classes | Increased Uterine Smooth Muscle Contraction or Tone [PE],Oxytocic [EPC],Oxytocin [Chemical/Ingredient] |